EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Net Income Summary of EASY BIO,Inc.

EASY BIO,Inc.'s latest annual net income in 2023 was 15.54 Billion KRW , up 70.24% from previous year.
EASY BIO,Inc.'s latest quarterly net income in 2024 Q2 was 4.34 Billion KRW , down -7.08% from previous quarter.
EASY BIO,Inc. reported an annual net income of 9.13 Billion KRW in 2022, down -16.02% from previous year.
EASY BIO,Inc. reported an annual net income of 10.87 Billion KRW in 2021, up 4.29% from previous year.
EASY BIO,Inc. reported a quarterly net income of 4.68 Billion KRW for 2024 Q1, down -1.22% from previous quarter.
EASY BIO,Inc. reported a quarterly net income of 3.74 Billion KRW for 2023 Q1, up 70.32% from previous quarter.

Annual Net Income Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Net Income of EASY BIO,Inc. (2023 - 2020)

Year	Net Income	Net Income Growth
2023	15.54 Billion KRW	70.24%
2022	9.13 Billion KRW	-16.02%
2021	10.87 Billion KRW	4.29%
2020	10.42 Billion KRW	0.0%

Year	Net Income	Net Income Growth
2024 Q2	4.34 Billion KRW	-7.08%
2024 Q1	4.68 Billion KRW	-1.22%
2023 Q1	3.74 Billion KRW	70.32%
2023 FY	15.54 Billion KRW	70.24%
2023 Q4	4.73 Billion KRW	32.84%
2023 Q3	3.56 Billion KRW	2.13%
2023 Q2	3.49 Billion KRW	-6.74%
2022 FY	9.13 Billion KRW	-16.02%
2022 Q3	2.49 Billion KRW	16.27%
2022 Q4	2.19 Billion KRW	-11.78%
2022 Q2	2.14 Billion KRW	1.67%
2022 Q1	2.1 Billion KRW	-14.6%
2021 Q1	3.11 Billion KRW	8.63%
2021 FY	10.87 Billion KRW	4.29%
2021 Q4	2.46 Billion KRW	-6.92%
2021 Q3	2.65 Billion KRW	0.58%
2021 Q2	2.63 Billion KRW	-15.3%
2020 FY	10.42 Billion KRW	0.0%
2020 Q4	2.86 Billion KRW	-39.38%
2020 Q3	4.72 Billion KRW	67.07%
2020 Q2	2.83 Billion KRW	0.0%

Peer Net Income Comparison of EASY BIO,Inc.

Name	Net Income	Net Income Difference
HLB Co., Ltd.	-189.07 Billion KRW	108.221%
iNtRON Biotechnology, Inc.	-9.69 Billion KRW	260.321%
BINEX Co., Ltd.	4.67 Billion KRW	-232.79%
Bioneer Corporation	-10.58 Billion KRW	246.819%
Anterogen.Co.,Ltd.	-2.84 Billion KRW	647.152%
MEDIPOST Co., Ltd.	5.83 Billion KRW	-166.161%
CrystalGenomics, Inc.	-48.92 Billion KRW	131.772%
Helixmith Co., Ltd	-64.08 Billion KRW	124.254%
Chabiotech Co.,Ltd.	-8.43 Billion KRW	284.359%
Medy-Tox Inc.	9.75 Billion KRW	-59.34%
Peptron, Inc.	-15.92 Billion KRW	197.625%
Amicogen, Inc.	-23.28 Billion KRW	166.743%
Genexine, Inc.	-66.87 Billion KRW	123.244%
HLB Therapeutics Co.,Ltd.	-2.3 Billion KRW	775.183%
LegoChem Biosciences, Inc.	-73.7 Billion KRW	121.09%
ALTEOGEN Inc.	-3.37 Billion KRW	560.998%
PharmaResearch Co., Ltd.	76.55 Billion KRW	79.695%
SillaJen, Inc.	-20.36 Billion KRW	176.31%
JETEMA, Co., Ltd.	13.96 Billion KRW	-11.298%
OliX Pharmaceuticals,Inc	-19.1 Billion KRW	181.374%
Genomictree Inc.	-8.75 Billion KRW	277.521%
MedPacto, Inc.	-35.32 Billion KRW	144.002%
D&D Pharmatech	3.93 Billion KRW	-295.133%
GI Innovation, Inc.	-55.49 Billion KRW	128.009%